Nexpamo Tablets (Famotidine)

Adult dose

1. For gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding, gastroesophageal reflux disease, Zollinger-Ellison syndrome: Administer famotidine 20 mg orally, twice daily (after breakfast, after dinner or before bedtime) or 40 mg orally once daily (at bedtime). In the case of upper gastrointestinal bleeding, treatment usually starts with injectable medication, and when oral administration becomes possible, switch to oral dosing. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, swelling) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis. Adults: Administer famotidine 10 mg orally, twice daily (after breakfast, after dinner, or before bedtime) or 20 mg orally once daily (at bedtime). Adjust dosage according to age and symptoms.

This medication should not be administered to specific patients. Individuals allergic to this drug's ingredients or other H2 receptor antagonists should not take it. Additionally, this medication contains lactose and should not be used by patients with lactose intolerance or certain genetic problems. It should be administered with caution to patients with impaired kidney function, heart disease, weakened liver function, and the elderly, as these patients may experience more severe side effects. During treatment with this medication, serious side effects such as allergic reactions, severe skin rash, blood abnormalities, liver dysfunction, muscle problems, cardiac arrhythmia, altered consciousness, kidney issues may occur, and if symptoms arise, a physician should be consulted immediately. While taking this medication, closely monitor changes in symptoms and start treatment at the minimum effective dose; if there is no effect, it is advisable to switch to another treatment method. This drug dissolves in the mouth but is not absorbed through the oral mucosa, so it must be swallowed with water. Patients undergoing dialysis should be cautious, as the efficacy of this drug may be reduced when used with phosphate binders. This medication may interact with certain other drugs, so be sure to inform healthcare providers of any other medications being taken. The elderly are likely to have reduced kidney function, which may increase the concentration of this drug, thus necessitating dosage adjustment or modification of dosing intervals. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this medication, and nursing mothers should refrain from breastfeeding as this drug may be excreted in breast milk. Safety in children has not been sufficiently established, so caution is required in its use. Finally, this medication may mask the symptoms of gastric cancer, so it should only be taken after ensuring that it is not gastric cancer.

Serious side effects

• Shock
• hypersensitivity
• anaphylaxis
• respiratory distress
• generalized flushing
• angioedema
• facial edema
• pharyngeal edema
• urticaria
• pancytopenia

Mild side effects

• Rash
• urticaria
• facial swelling
• constipation
• diarrhea
• loose stools
• dry mouth
• nausea
• vomiting
• abdominal bloating

This medication may be sensitive to air or moisture and should be stored in a sealed container. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain its efficacy.

Appearance

Pale green circular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle